Table 2.
Patients Who Had Surgical Intervention.
| 2019 | 2020 | P-Value | ||
|---|---|---|---|---|
| Number of patients | 158 | 72 | .08 | |
| Age | 48.9 ± 21.4 | 49.36 ± 20.75 | .87 | |
| Gender (male/female) | 87/71 | 44/28 | .39 | |
| Charlson comorbidity index | .82 ± 1.59 | .96 ± 1.74 | .56 | |
| APACHE-II score | 3.98 ± 3.75 | 6.15 ± 4.64 | .003 | |
| Median time to hospitalization | 9:23 (6:14-13:18) | 6:56 (4:15-10:02) | .72 | |
| Median time to surgical intervention | 19:01 (10:22-42:25) | 11:00 (7:27-23:26) | <.001 | |
| Median duration of surgery | 1:04 (0:29-1:41) | 1:14 (0:42-2:10) | <.001 | |
| LOS from surgery | 5.69 ± 10.43 | 5.06 ± 6.6 | .588 | |
| Presence of attending | 70 (44.3%) | 41 (56.9%) | .031 | |
| Laparoscopic surgery | 84 (53.2%) | 30 (41.7%) | .011 | |
| Intraoperative complication (Delphi study) | 9 (5.7%) | 7 (9.7%) | .091 | |
| Postoperative | ||||
| Complications (Clavien-Dindo score) | 1 | 5 (3.2%) | 5 (6.9%) | .019 |
| 2 | 21 (13.3%) | 9 (12.5%) | .053 | |
| 3a | 1 (.6%) | 1 (2.8%) | .02 | |
| 3b | 3 (1.9%) | 3 (2.8%) | .047 | |
| 4 | 1 (.6%) | 1 (1.4%) | .044 | |
| 5 | 5 (3.2%) | 2 (2.8%) | .053 | |
| Major complication CD ≥ 3 | 10 (6.3%) | 7 (9.7%) | .03 | |
| Number of PRBC during hospitalization | .08 .42 | .42 1.58 | .013 | |
| LOS | 5.69 10.43 | 5.06 6.7 | .65 | |
| In-hospital mortality | 5 (3.1%) | 4 (5.5%) | .326 | |
| 30-day readmission | 10 (6.49%) | 6 (11.1%) | .273 | |
| 30-day mortality | 4 (2.53%) | 4 (5.5%) | .12 | |
Abbreviation: CD, Clavien-Dindo; LOS, length of stay; PRBC, packed red blood cells.